Finally, a dataset covering the different stages of hepatocellular carcinoma showed a trend of progressive increase in ZNF385A and ZNF346 expression, from chronic hepatitis to hepatocellular carcinoma ( Figure 7 C,D).
← all excerpts
<i>ZNF385A</i> and <i>ZNF346</i> Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma.
1
—
—